1. Home
  2. VALN vs CCRN Comparison

VALN vs CCRN Comparison

Compare VALN & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • CCRN
  • Stock Information
  • Founded
  • VALN 2012
  • CCRN 1986
  • Country
  • VALN France
  • CCRN United States
  • Employees
  • VALN N/A
  • CCRN N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • CCRN Professional Services
  • Sector
  • VALN Health Care
  • CCRN Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • VALN 542.5M
  • CCRN 447.2M
  • IPO Year
  • VALN 2021
  • CCRN N/A
  • Fundamental
  • Price
  • VALN $6.59
  • CCRN $12.11
  • Analyst Decision
  • VALN Strong Buy
  • CCRN Hold
  • Analyst Count
  • VALN 3
  • CCRN 5
  • Target Price
  • VALN $15.33
  • CCRN $17.93
  • AVG Volume (30 Days)
  • VALN 14.9K
  • CCRN 236.5K
  • Earning Date
  • VALN 08-12-2025
  • CCRN 07-30-2025
  • Dividend Yield
  • VALN N/A
  • CCRN N/A
  • EPS Growth
  • VALN N/A
  • CCRN N/A
  • EPS
  • VALN N/A
  • CCRN N/A
  • Revenue
  • VALN $201,099,222.00
  • CCRN $1,258,238,000.00
  • Revenue This Year
  • VALN $18.74
  • CCRN N/A
  • Revenue Next Year
  • VALN $29.26
  • CCRN $5.69
  • P/E Ratio
  • VALN N/A
  • CCRN N/A
  • Revenue Growth
  • VALN 21.64
  • CCRN N/A
  • 52 Week Low
  • VALN $3.62
  • CCRN $9.58
  • 52 Week High
  • VALN $8.66
  • CCRN $18.50
  • Technical
  • Relative Strength Index (RSI)
  • VALN 72.04
  • CCRN 27.64
  • Support Level
  • VALN $5.82
  • CCRN $11.77
  • Resistance Level
  • VALN $6.19
  • CCRN $13.60
  • Average True Range (ATR)
  • VALN 0.31
  • CCRN 0.40
  • MACD
  • VALN 0.11
  • CCRN -0.10
  • Stochastic Oscillator
  • VALN 100.00
  • CCRN 13.11

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: